Treatment of prdc in pigs

Treatment of prdc in pigs

  • CN 102,872,457 A
  • Filed: 01/02/2008
  • Published: 01/16/2013
  • Est. Priority Date: 01/03/2007
  • Status: Active Application
First Claim
Patent Images

1. PCV2 antigen or contain the pharmaceutical applications of the immunogenic composition of PCV2 antigen, described medicine is for the porcine respiratory disease complex (PRDC) of prevention animal and/or any clinical indication relevant with PRDC and treats the medicine of the clinical indication of being correlated with PRDC of animal, and wherein the clinical indication relevant with PRDC is selected from the group that is comprised of cough and dyspnea, poor growth, feed efficiency reduction, lethargy, anorexia, viremia

  • and/or viral load.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×